MRI monitoring of tumor response to a novel VEGF tyrosine kinase inhibitor in an experimental breast cancer model

被引：19
|
作者：
Turetschek, K [1 ]
Preda, A
Floyd, E
Shames, DM
Novikov, V
Roberts, TPL
Wood, JM
Fu, YJ
Carter, WO
Brasch, RC
机构：
[1] Univ Calif San Francisco, Dept Radiol, Ctr Pharmaceut & Mol Imaging, San Francisco, CA USA
[2] Univ Vienna, Dept Radiol, A-1090 Vienna, Austria
[3] Pfizer Cent rs, Groton, CT USA
[4] Novartis Pharma AG Ltd, Dept Oncol Res, Basel, Switzerland
来源：
ACADEMIC RADIOLOGY | 2002年 / 9卷
关键词：
D O I：
10.1016/S1076-6332(03)80281-7
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S519 / S520
页数：2
相关论文
共 50 条
  • [41] A specific VEGF-R tyrosine kinase inhibitor enhances the antiproliferative effect of trastuzumab in ErbB-2 overexpressing breast cancer cells
    Kim, E.
    Lobocki, C. A.
    Dubay, L.
    Mittal, V.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 48 - 49
  • [42] Treatment with a VEGF receptor tyrosine kinase inhibitor alleviates chronic skin inflammation in a mouse model of psoriasis
    Halin, C.
    Fahrngruber, H.
    Meingassner, J. G.
    Bold, G.
    Littlewood-Evans, A.
    Stuetz, A.
    Detmar, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S3 - S3
  • [43] Understanding the kinomic contributions to tyrosine kinase inhibitor resistance in triple negative breast cancer
    Lefebvre, Cory
    Litchfield, David
    Allan, Alison
    CANCER RESEARCH, 2019, 79 (13)
  • [44] Discovery of an EGFR tyrosine kinase inhibitor from Ilex latifolia in breast cancer therapy
    Wang, Cunqin
    Wang, Rongbin
    Chen, Ying
    Wang, Lei
    Zhou, Shoubiao
    Wang, Hongting
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (11) : 1282 - 1290
  • [45] Preclinical evaluation of the tyrosine kinase inhibitor SU11248 for the treatment of breast cancer
    Abrams, TJ
    Murray, LJ
    Pryer, NK
    Garcia, R
    Potapova, O
    Laird, AD
    Manning, JWC
    Pesenti, E
    Cherrington, JM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S75 - S75
  • [46] INHIBITION OF BREAST-CANCER CELL-GROWTH INVITRO BY A TYROSINE KINASE INHIBITOR
    REDDY, KB
    MANGOLD, GL
    TANDON, AK
    YONEDA, T
    MUNDY, GR
    ZILBERSTEIN, A
    OSBORNE, CK
    CANCER RESEARCH, 1992, 52 (13) : 3636 - 3641
  • [47] VEGF-associated tyrosine kinase inhibition increases the tumor response to single and fractionated dose radiotherapy
    Brazelle, William D.
    Shi, Wenyin
    Siemann, Dietmar W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (03): : 836 - 841
  • [48] Response to a Novel Multitargeted Tyrosine Kinase Inhibitor Pazopanib in Metastatic Merkel Cell Carcinoma
    Davids, Matthew
    Charlton, Amanda
    Ng, Swee-Siang
    Chong, Mei-Ling
    Laubscher, Kevin
    Dar, Mohammed
    Hodge, Jeffrey
    Soong, Richie
    Goh, Boon Cher
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) : E97 - E100
  • [49] Tyrosine-Derived Novel Benzoxazine Active in a Rat Syngenic Mammary Tumor Model of Breast Cancer
    Jana, Amit Kumar
    Singh, Jyotsana
    Ganesher, Asha
    Kumar, Amit
    Banerjee, Arpita
    Kumar, Deepak
    Verma, Sarvesh Kumar
    Sharma, Ashok Kumar
    Bhatta, Rabi Sankar
    Konwar, Rituraj
    Panda, Gautam
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (21) : 16293 - 16316
  • [50] Tumor Heterogeneity for Assessment of Response to Tyrosine Kinase Inhibitors in Patients with Thyroid Cancer
    Bundschuh, R. A.
    Hartl, J.
    Zsoter, N.
    Papp, L.
    Biko, J.
    Buck, A. K.
    Lapa, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S240 - S240
12345